The dyslipoproteinemias of diabetes

Atherosclerosis
George Steiner

Abstract

Atherosclerosis is the most frequent complication of diabetes. There are many potentially atherogenic factors in diabetes that may underlie this problem. Of these, one is the group of dyslipoproteinemias. In diabetes there are both qualitative and quantitative changes in the plasma lipoproteins. Based on pathophysiological and epidemiological data, these may be among the many factors that can result in early macrovascular disease. Furthermore, at least one of the dyslipoproteinemias--hypertriglyceridemia--is associated with insulin resistance and therefore could aggravate glucose intolerance. Thus, on theoretical grounds it is reasonable to postulate that treating the dyslipoproteinemias of diabetes would reduce atherosclerotic disease. However, to date there have been no intervention studies specifically designed to test this postulate in the diabetic population. One such study, the Diabetes Atherosclerosis Intervention Study, is currently in progress.

References

Dec 1, 1992·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·K R FeingoldR M Krauss
Jan 1, 1992·British Medical Bulletin·P G Burney
Oct 1, 1991·Diabetes Research and Clinical Practice·S Zuniga-GuarjardoB Zinman
Jul 1, 1985·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·M PoapstG Steiner
Nov 1, 1984·Metabolism: Clinical and Experimental·W P BiegerA Wirth
Sep 1, 1984·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·B V HowardP H Bennett
Jan 1, 1981·Diabetes·E A Nikkilä
May 1, 1982·Metabolism: Clinical and Experimental·M F ReardonG Steiner
Jul 1, 1982·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·A KuksisJ A Little
Sep 1, 1951·The American Journal of Medicine·H B JONESA V NICHOLS

Citations

Sep 18, 1998·Diabetes Research and Clinical Practice·H Haller
Oct 6, 1997·Endocrinology and Metabolism Clinics of North America·P M Bell, D R Hadden
Nov 5, 1997·Annals of the New York Academy of Sciences·P BohovI Klimes
Jan 29, 2005·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Jairo A BertiHelena C F Oliveira
Feb 9, 2016·Atherosclerosis·Fumiyoshi TsunodaBela F Asztalos
Apr 30, 2009·Proteomics·Matthew R RichardsonFrank A Witzmann
Aug 26, 1998·The American Journal of Medicine·P C Deedwania
Oct 29, 2000·Diabetic Medicine : a Journal of the British Diabetic Association·T M DavisI R Mackay
Dec 11, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·J L DixonM Sturek
Jan 27, 2012·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Gopalakrishnan RamakrishnanNimai C Chandra
Jul 15, 2004·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·P K Horvit, A J Garber
Dec 4, 2020·International Journal of Molecular Sciences·Christina E KostaraVasilis Tsimihodimos

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.